Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marubeni Pharma is a specialized trading company and a wholly-owned subsidiary of Marubeni Corporation, one of Japan's largest general trading houses. The company focuses on the pharmaceutical industry, providing a comprehensive range of services including the sourcing and distribution of active pharmaceutical ingredients (APIs), intermediates, and additives. Marubeni Pharma also facilitates the import and export of finished dosage forms and offers support for contract manufacturing and regulatory affairs. By utilizing its parent company's extensive global network, it acts as a vital link between international manufacturers and the Japanese healthcare market. Its business model emphasizes supply chain management and market entry support for foreign pharmaceutical entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marubeni Pharmaceutical.